FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
30/01/2024
Voltar para busca
Dado oficial do USPTO
BARRIOLIDES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BARRIOLIDES
ST13
US500000079346405Classe
1, 5, 42
Pedido
79346405
Registro
7178487
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
30/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
09/06/2022
Data de registro
03/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/10/2023
Última transação
03/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
78
Localização do titular
IS
Examinador
KAJUBI, ELIZABETH
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
E. E. (pessoa física)
Representantes
Susan Fentress Veritay Group IP, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; biological preparations for use in industry and science
Classe 5
Pharmaceutical and veterinary preparations to improve function of membranes in the body; pharmaceutical and veterinary preparations to improve function of membranes in the lung; pharmaceutical and veterinary preparations to enhance the epithelial barrier; pharmaceutical and veterinary preparations to enhance the airway epithelial barrier; pharmaceutical and veterinary preparations to inhibit inflammation; pharmaceutical and veterinary preparations for the treatment of a disease or condition that is caused by a defect in epithelial cells or tissue; pharmaceutical and veterinary preparations for the treatment of a disease or condition that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of a disease or condition of epithelial tissue in the respiratory tract; pharmaceutical and veterinary preparations for the treatment of epithelial dysfunction; pharmaceutical and veterinary preparations for the treatment of human airway epithelial cells; pharmaceutical and veterinary preparations for the treatment of chronic respiratory diseases; pharmaceutical and veterinary preparations for the treatment of viral airways diseases; pharmaceutical and veterinary preparations for the treatment of an airways disease; pharmaceutical and veterinary preparations for the treatment of asthma; pharmaceutical and veterinary preparations for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and veterinary preparations for the treatment of cystic fibrosis; pharmaceutical and veterinary preparations for the treatment of non-cystic fibrosis bronchiectasis; pharmaceutical and veterinary preparations for the treatment of chronic rhinosinusitis; pharmaceutical and veterinary preparations for the treatment of diffuse panbronchiolitis (DPB); pharmaceutical and veterinary preparations for the treatment of chronic bronchitis; pharmaceutical and veterinary preparations for the treatment of bronchiolitis obliterans organizing pneumonia (BOOP); pharmaceutical and veterinary preparations for the treatment of infantile respiratory distress syndrome (IRDS); pharmaceutical and veterinary preparations for the treatment of bronchopulmonary dysplasia; pharmaceutical and veterinary preparations for the treatment of neuromuscular respiratory depression or failure; pharmaceutical and veterinary preparations for the treatment of pneumonia; pharmaceutical and veterinary preparations for the treatment of conditions caused by and associated with respiratory syncytial virus (RSV) and related viruses; pharmaceutical and veterinary preparations for the treatment of a disease or condition commonly associated with inflammation that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of systemic inflammatory distress syndrome (SIRS); pharmaceutical and veterinary preparations for the treatment of adult respiratory distress syndrome (ARDS); pharmaceutical and veterinary preparations for the treatment of inflammatory bowel disease; pharmaceutical and veterinary preparations for the treatment of ulcerative colitis; pharmaceutical and veterinary preparations for the treatment of Crohn's disease; sanitary preparations for medical purposes; dietary supplements for human beings and animals
Classe 42
Scientific and technological services and research and design relating theretoscientific research in the field of pharmaceutical studies researchscientific research in new pharmaceutical design servicesmedical and pharmacological research servicesdrug discovery servicespharmaceutical drug development servicespharmaceutical research and development; industrial analysis and research servicespharmaceutical analysis and pharmaceutical research
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/01/2024
FIMP
FINAL DISPOSITION PROCESSED
08/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/07/2023
PUBO
PUBLISHED FOR OPPOSITION
18/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/06/2023
RFNT
REFUSAL PROCESSED BY IB
18/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/05/2023
RFRR
REFUSAL PROCESSED BY MPU
22/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/03/2023
CNRT
NON-FINAL ACTION WRITTEN
30/03/2023
DOCK
ASSIGNED TO EXAMINER
24/03/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/08/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
28/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BARRIOLIDES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.